Arcus Biosciences Company
Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.
Investors
Employee Number:
101-250
Investors Number:
17
Funding Status:
IPO
Headquarters:
Hayward, California, United States
Technology:
Anti-infective Drugs
Estimated Revenue:
$1M to $10M
Founded Date:
2015
Last Funding Type:
Series C
Investor Type:
N/A
Total Funding:
$226.7M
Number Of Exists:
N/A
Investment Stage:
N/A
Industry:
PharmTech